CPH Pharma ApS: Financial statements 2023
CVR: 37110248
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CPH Pharma ApS (CVR 37110248) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,016,998 and a net result of DKK 1,034,324 compared with DKK 586,524 the year before. That is an increase of 72.7% compared with the year before. Equity in the 2023 report amounted to DKK 1,963,308. The solvency ratio was 68.1%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,016,998
- Profit/Loss
- DKK 1,034,324
- Equity
- DKK 1,963,308
- Total Assets
- DKK 2,883,491
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3 mio. | 1 mio. | 2 mio. | 3 |
| 2022 | - | 1.7 mio. | 587 t. | 1.3 mio. | 2 |
| 2021 | - | 1.6 mio. | 895 t. | 1 mio. | 1 |
| 2020 | - | 1 mio. | 480 t. | 447 t. | 1 |
| 2019 | - | 799 t. | 575 t. | -33 t. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CPH Pharma ApS has published its annual report for 2022. Gross profit came to DKK 1,747,395, and the net result was DKK 586,524.
About CPH Pharma ApS
CPH Pharma ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Kamran Khasadar. The company is owned by Qi Holding APS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. Equity in the 2025 report amounted to DKK 3,102,300.